Team and Valois Pharmaceutical Division partner on new dry powder inhaler development

13 Apr 2004 2min read

Team Consulting

Company update

Team Consulting and Valois Pharmaceutical Division today announced they have embarked upon a major development programme to produce a novel breath-actuated multi-dose Dry Powder Inhaler (DPI).

The ‘Bead Inhaler’ will utilise a unique dispersion technology proven to deliver excellent aerosolisation performance, reproducible emitted dose and high fine particle fraction. A novel drug storage and release technology is also being developed. In addition to offering excellent delivery performance and moisture protection with a wide range of formulations, the inhaler will be compact and simple to use.

This programme reflects a strong relationship between Valois, the pharmaceutical manufacturing and packaging experts, and Team, who have a depth of experience in medical and drug delivery device development.

Salim Haffar, Associate Director, Business Development Valois, said, “Team’s skills and proven track record in developing inhalation devices make them an ideal partner to help Valois in achieving its development milestones for the ‘Bead Inhaler’.

Helen Slaski, Commercial Director, Team, added, “We’re very excited to be working on this innovative development. The combined expertise of Valois and Team and our established relationship will deliver a product which offers great benefit to users.

Image source:

Join the conversation

Looking for industry insights? Click below to get our opinions and thoughts into the world of
medical devices and healthcare.